๐Ÿ•ต๏ธ Jasper Therapeutics, Inc. ($JSPRW)

SEC insider & ownership activity, last 12 months ยท CIK 1788028 ยท every row links its SEC filing

Insider buy value was withheld pending verification over the last 12 months. One red-flag 8-K in the window: Delisting notice (3.01), Jun 3, 2026.

Insider flow

4 buyers, value withheld pending verification (4 lots) ยท 0 sellers, $0 (0 lots)

InsiderBuysBoughtSellsSoldLast
Thomas G. Wiggans1value withheld pending verification 0โ€“Sep 22, 2025
Lucas Svetlana1value withheld pending verification 0โ€“Sep 22, 2025
Martell Ron1value withheld pending verification 0โ€“Sep 22, 2025
Shizuru Judith Anne1value withheld pending verification 0โ€“Sep 22, 2025

5%+ holders

HolderStakeClassScheduleEvent
Soleus GP LLC 10.0% 13GFeb 11, 2025 filing โ†—
Velan Capital Investment Management LP 9.9% 13GAug 17, 2026 filing โ†—
Velan Capital Management LLC 9.9% 13GAug 17, 2026 filing โ†—
Morgan Adam 9.9% 13GAug 17, 2026 filing โ†—
Venkataraman Balaji 9.9% 13GAug 17, 2026 filing โ†—
Velan Capital Investment Management LP 9.9% 13DJul 16, 2026 filing โ†—
Velan Capital Management LLC 9.9% 13DJul 16, 2026 filing โ†—
Morgan Adam 9.9% 13DJul 16, 2026 filing โ†—
Venkataraman Balaji 9.9% 13DJul 16, 2026 filing โ†—
Velan Capital Master Fund LP 8.9% 13GAug 17, 2026 filing โ†—
Velan Capital Holdings LLC 8.9% 13GAug 17, 2026 filing โ†—
Velan Capital Master Fund LP 8.9% 13DJul 16, 2026 filing โ†—
Velan Capital Holdings LLC 8.9% 13DJul 16, 2026 filing โ†—
T. ROWE Price Investment Management, Inc. 7.1% 13GNov 14, 2025 filing โ†—
Anders Hove 5.3% 13GJan 26, 2026 filing โ†—
Kingdon Capital Management, L.L.C. 5.1% 13GJul 11, 2025 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Material agreement (1.01)Aug 21, 2026 filing โ†—
Earnings (2.02)Aug 14, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 14, 2026 filing โ†—
Shareholder vote (5.07)Jul 31, 2026 filing โ†—
Other events (8.01)Jul 31, 2026 filing โ†—
Material agreement (1.01)Jul 16, 2026 filing โ†—
Acquisition or disposition (2.01)Jul 16, 2026 filing โ†—
Unregistered equity sale (3.02)Jul 16, 2026 filing โ†—
Officer/director changes (5.02)Jul 16, 2026 filing โ†—
Charter/bylaw changes (5.03)Jul 16, 2026 filing โ†—
Reg FD disclosure (7.01)Jul 16, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jul 16, 2026 filing โ†—
Reg FD disclosure (7.01)Jul 16, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jul 16, 2026 filing โ†—
Delisting notice (3.01)Jun 3, 2026 filing โ†—
Reg FD disclosure (7.01)Jun 1, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 1, 2026 filing โ†—
Officer/director changes (5.02)May 15, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 15, 2026 filing โ†—
Earnings (2.02)May 14, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 14, 2026 filing โ†—
Earnings (2.02)Mar 30, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 30, 2026 filing โ†—
Other events (8.01)Jan 8, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jan 8, 2026 filing โ†—
Officer/director changes (5.02)Jan 2, 2026 filing โ†—
Other events (8.01)Jan 2, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jan 2, 2026 filing โ†—
Other events (8.01)Dec 2, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Dec 2, 2025 filing โ†—